Skip to content

Protective lung ventilation strategy in patients undergoing minimally invasive coronary artery bypass grafting: a randomized cotrolled trial

Protective lung ventilation strategy in patients undergoing minimally invasive coronary artery bypass grafting: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022005
Enrollment
Unknown
Registered
2019-03-20
Start date
2019-03-28
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

Protective lung ventilation group:Protective lung ventilation
Conventionnal lung ventilation group:Conventionnal lung ventilation

Sponsors

Department of Anesthesiology, Peking University Third Hospital, Beijing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patient going to have selective small incision coronary artery bypass grafting under general anesthesia; 2. ASA grade I~III; 3. Expected survival time >3 months; 4. Can cooperate to observe adverse events and effects; 5. The patient or his legal representative signs a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. BMI> 40 kg/m2; 2. Patients with a history of pulmonary surgery or respiratory insufficiency, pulmonary infection, active asthma; 3. Chronic renal insufficiency (serum creatinine > 200 µmol/L); 4. Hepatic insufficiency (Child-Pugh grade B or above); 5. Hemodynamically unstable; 6. The patient has undergone long-term hormonal therapy or is in pregnancy; 7. Progressive neuromuscular disease; 8. The body temperature is above 38 degree C or there are obvious clinical infections that can affect clinical trials.

Design outcomes

Primary

MeasureTime frame
Oxygenation index;

Secondary

MeasureTime frame
Postoperative pulmonary complication rate;levels of perioperative serum inflammatory factors;

Countries

China

Contacts

Public ContactXu Mao

Department of Anesthesiology, Peking University Third Hospital, North Garden Rd.,Haidian District Beijing ,P.R.China

anae@163.com+86 18911482830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026